News
-
-
-
PRESS RELEASE
Wellgistics Health Secures $50M Credit Facility and Launches XRP-Powered Payment Initiative
Wellgistics Health, Inc. unveils XRP payment initiative to revolutionize healthcare finance with speed, cost efficiency, and transparency. The initiative aims to streamline transactions and enhance liquidity in the healthcare ecosystem -
-
-
-
-
-
-
PRESS RELEASE
Broad-Spectrum Antiviral Drug NV-387 Cleared for Phase II Clinical Trial Application by the National Ethics Committee of the Democratic Republic of Congo
NanoViricides, Inc. receives approval from CNES for Phase II clinical trial of NV-387 in DRC for MPox disease treatment. CEO highlights drug's broad-spectrum antiviral capabilities